Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy
- 1 December 1984
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 58 (4), 689-696
- https://doi.org/10.1111/j.1365-2141.1984.tb06116.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Identical Twin Marrow Transplantation in Multiple MyelomaActa Haematologica, 1982
- REAPPRAISAL OF PLATEAU PHASE IN MYELOMAThe Lancet, 1980
- Smoldering Multiple MyelomaThe New England Journal of Medicine, 1980
- Leukemic Myelomatosis (Plasma Cell Leukemia)American Journal of Clinical Pathology, 1978
- Unmaintained remissions in multiple myelomaBlood, 1978
- Monoclonal gammopathy of undetermined significance: Natural history in 241 casesThe American Journal of Medicine, 1978
- Differentiation Between Benign and Malignant Monoclonal Gammopathies by Discriminant Analysis on Serum and Bone Marrow ParametersActa Haematologica, 1978
- High Speed Scintillation AutoradiographyScience, 1975
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Total body irradiation for myelomatosis.BMJ, 1971